Ergoteles LLC Myriad Genetics Inc Transaction History

Ergoteles LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$17.56 - $23.76 $18,859 - $25,518	1,074 Added 3.89%	28,710 $665,000
Q1 2023 May 10, 2023	BUY	$15.26 - $23.75 $168,668 - $262,508	11,053 Added 66.65%	27,636 $641,000
Q4 2022 Feb 14, 2023	BUY	$14.51 - $20.99 $240,619 - $348,077	16,583 New	16,583 $240,000
Q2 2022 Aug 12, 2022	BUY	$16.45 - $25.88 $471,078 - $741,125	28,637 New	28,637 $520,000

253

90.5M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.11B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.